Clinical trial
US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study…
NCT00085852 · Aeris Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00085852 |
|---|---|
| Title | US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation |
| Official title | Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema |
| Lead sponsor | Aeris Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Emphysema |
| Intervention type | Biological |
| Interventions | BLVR |
| Enrollment | 6 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jun 17, 2004 |
| Last update posted | Mar 6, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: